About Jeremy

Jeremy has a bachelor’s degree (BA) in Mathematics and Philosophy from St John’s College in Annapolis, Maryland, master’s degrees (MA, MSc) in Economics and Agricultural and Applied Economics from the University of Wisconsin, Madison, and a doctorate in Public Health (PhD) from Erasmus University Rotterdam.

Since 2000 Jeremy has been working on the use and interpretation of mathematical models in economic evaluation and related fields and has contributed to an influential body of work on the cost effectiveness of interventions for cardiovascular risk factors and disease, respiratory conditions, cancers, maternal and child health, HIV/AIDS, tuberculosis and chronic disease prevention, as well as on health systems research and diverse topics in epidemiology and statistics.

Jeremy has led inter-disciplinary teams in a range of countries in Latin America and Africa on adapting results of economic evaluation to national settings, and, with colleagues, he is currently engaged in finalizing a major research update on the cost effectiveness of more than 500 interventions covering 22 distinct areas of diseases, injuries and risk factors (WHO-CHOICE). More recently, Jeremy has been studying the economics of fiscal space for the health workforce, as well as interactions between the health system and the broader economy, for the UN Secretary-General’s High-Level Commission on Health Employment and Economic Growth, and he led the work on WHO’s related contributions to that Commission.

Jeremy is currently working on the financing of public goods in health and also on deconstructing the public/private divide in the health system.

This speaker will be presenting at the following session(s)

  • Strategic direction 4: financing for sustainability

    Golden Hall

    Day: 3 November

    Time: 09:00

    The first of two plenary sessions on strategic direction 4, which addresses the sustainable financing of hepatitis responses within a whole health systems approach.

    Chairs: Dr. Amanda Kgomotso Vilakazi Nhlapo, National Department of Health, South Africa and Dr. John Ward, US Centers for Disease Control and Prevention

    Presentations:

    • A strategic approach to financing hepatitis.
      Charles Gore, World Hepatitis Alliance
    • Costing, delivery and financing for hepatitis – the linkages.
      Dr. Jeremy Lauer, World Health Organization
    • Panel discussion: financing for hepatitis within a health systems approach.
      Moderator: Dr. Eduardo González Pier, Center for Global Development
      Dr. David Wilson, World Bank
      Dr. Jean Damascene Makuza, Rwanda Biomedical Center
      Dr. Jeremy Lauer, World Health Organization
      Dr. Homie Razavi, Center for Disease Analysis Foundation

      Dr. Cielo Yaneth Ríos-Hincapié, Ministry of Health and Social Protection, Colombia

    Session objective:

    • Discover how to approach hepatitis costing, budgeting and financing in a structured way.
    • Understand how the financing system must match the service delivery model and where there are opportunities for integration.
    • Learn how countries can best approach sustainable financing for hepatitis.
  • Different financing mechanisms for viral hepatitis programmes

    Golden Hall

    Day: 3 November

    Time: 11:00

    This session examines potential hepatitis financing mechanisms that will be required for countries to launch, accelerate and sustain public health responses to viral hepatitis.

    Chairs: Dr Adele Benzaken, Ministry of Health, Brazil and Dr. Philippe Duneton, Unitaid

    Presentations:

    • From economic analysis to financial dialogue.
      Dr. Homie Razavi, Center for Disease Analysis Foundation
    • A new Fund for Elimination of Viral Hepatitis: EndHEP2030.
      Wangsheng Li, Zeshan Foundation
    • Getting started with funding: catalytic initiatives.
      Taryn Barker, Clinton Health Access Initiative
    • Engaging Ministries of Finance.
      Eduardo González-Pier, Center for Global Development
    • Domestic funding.
    • Jeremy Lauer, World Health Organization, in conversation with Dr. Chinburen Jigjidsuren, Ministry of Health, Mongolia
    • Q & A session.

    Session objectives:

    • Understand the global investment case and its use in attracting donors.
    • Learn how to ensure the support of Ministries of Finance.
    • Understand how the public and private sector can be combined.
    • Discover how 3 countries have approached hepatitis financing.